June 1-5 – American Society of Clinical Oncology Annual Meeting in Chicago.
June 6 – House Oversight and Government Reform Committee is holding a FDA's Drug Safety Evaluation of Avandia. It is a full committee hearing on the Food and Drug Administration’s role in evaluating the safety of the diabetes drug Avandia. Steven Nissen, author of the "New England Journal of Medicine" report on Avandia; FDA Commissioner Andrew von Eschenbach; and Jean-Pierre Garnier, CEO of GlaxoSmithKline, which makes Avandia.
June 7 – American Enterprise Institute for Public Policy is holding a policy discussion, "Who Killed Health Care? Is It Really Dead?" Harvard Business School professor Regina Herzlinger argues that the health-care system can be redesigned to produce better, less costly health care only if individuals are allowed to take back control over the decisions that deeply affect their health and their pocketbooks. Herzlinger makes the case that consumers would be better off buying their own insurance coverage rather than allowing employers and government to decide what health coverage they must have--a coverage paid for by lower wages and higher taxes.
No comments:
Post a Comment